Identifying key challenges and optimizing approaches for training of health care professionals for HPV vaccination programmes

Vaccine. 2024 Jul 11:42 Suppl 2:S22-S26. doi: 10.1016/j.vaccine.2023.10.064. Epub 2024 Nov 7.

Abstract

Healthcare professionals (HCPs) play a crucial role in building vaccine confidence and promoting vaccination programmes. HCP vaccination recommendations are often the strongest predictor of vaccine uptake, influencing individuals' acceptance of and demand for vaccination. However, HCP training on human papillomavirus (HPV) vaccination faces challenges in some countries, including Ethiopia, Malawi, and Uganda. This study summarizes the discussions held during the Coalition to Strengthen HPV Immunization Community Symposium in Africa, the field experiences of co-authors, and expert opinions to inform its findings. Key challenges faced in these countries are maintaining regular and comprehensive HCP training, ensuring continuity due to staff turnover, reaching all health facilities, and including teachers as key mobilizers. Funding constraints, limited communication materials, and human resource shortages can further impact training effectiveness. Recommendations for strengthening HCP training on HPV vaccination programmes include providing adequate training to all HCPs, refresher training, including private sector HCPs and teachers, leveraging local training institutions, and integrating HPV vaccine training into pre-service HCP academic curricula. These actions would be essential for improving HPV vaccine coverage and working towards cervical cancer elimination goals.

Keywords: HPV vaccination programs; Healthcare professionals; National immunization; Training.

MeSH terms

  • Ethiopia
  • Female
  • Health Personnel* / education
  • Humans
  • Immunization Programs*
  • Malawi
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines* / administration & dosage
  • Uganda
  • Uterine Cervical Neoplasms / prevention & control
  • Vaccination Coverage / statistics & numerical data
  • Vaccination*

Substances

  • Papillomavirus Vaccines